EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biomimetic Copper‐Doped Nano‐Aluminum Adjuvant Potentiates Therapy in Chemoresistant Acute Myeloid Leukemia

Chao He, Lingxiao Zhang, Yue Xiong, Yu Wang, Yuqing Zeng, Dandan Su, Ran Wang, Ying Li, Hongbo Chen, Fang Cheng, Zhi Ping Xu iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202504039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Chao He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, P. R. China. Hauptthemen laut MEDLINE: Copper, Leukemia, Myeloid, Acute, Drug Resistance, Neoplasm, Aluminum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Bay Laboratory Start-Up Fund, National Key R&D Program of China, Key Project of Shenzhen Natural Science Foundation, European Union's Research and Innovation Program under the Marie Skłodowska-Curie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is a hematologic malignancy with frequent resistance to first‐line cytarabine‐based chemotherapy, primarily driven by heightened mitochondrial function. Here, we develop a copper‐doped nano‐aluminum adjuvant (CuNA) to overcome this resistance by targeting mitochondrial vulnerability. Upon internalization, CuNA releases Cu 2 + , leading to intracellular Cu 2+ overload, which disrupts mitochondrial function and induces ferroptosis in drug‐resistant AML cells, thereby markedly enhancing cytarabine sensitivity. Moreover, CuNA downregulates cholesterol biosynthesis and antioxidant defense pathways, including suppression of HMG‐CoA reductase and glutathione peroxidase 4, further amplifying ferroptosis in combination with cytarabine. In drug‐resistant AML mouse models, CuNA coated with AML cell membranes demonstrates efficient tumor targeting, robust suppression of leukemia progression, and prolonged survival. This study highlights CuNA as a promising tool to overcome chemoresistance mediated by mitochondrial reprogramming in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperLeukemia, Myeloid, AcuteDrug Resistance, NeoplasmAluminumBiomimetic MaterialsAnimalsMiceHumansCytarabineCell Line, TumorMitochondriaFerroptosis

Stichwörter der Autor:innen

copper overloadcytarabine‐resistant acute myeloid leukemiaferroptosisheightened mitochondrial functionnano‐aluminum adjuvant

Substanzen

CopperCytarabineAluminum

Autor:innen und Institutionen

  • Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, P. R. China.
  • Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, Denmark.
  • Department of Pharmacy, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, P. R. China.
  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, P. R. China.
  • The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Zhi Ping Xu

Förderung

  • Shenzhen Bay Laboratory Start-Up Fund, National Key R&D Program of China
  • Key Project of Shenzhen Natural Science Foundation
  • European Union's Research and Innovation Program under the Marie Skłodowska-Curie
  • Natural Science of Guangdong Province
  • Natural Science Foundation of Ningbo Municipality
  • Open Project of State Key Laboratory of Respiratory Diseases

Zitieren

APA

He, C., Zhang, L., Xiong, Y., Wang, Y., Zeng, Y., Su, D., Wang, R., Li, Y., Chen, H., Cheng, F., & Xu, Z. P. (2026). Biomimetic Copper‐Doped Nano‐Aluminum Adjuvant Potentiates Therapy in Chemoresistant Acute Myeloid Leukemia. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504039

Vancouver

He C, Zhang L, Xiong Y, Wang Y, Zeng Y, Su D, et al. Biomimetic Copper‐Doped Nano‐Aluminum Adjuvant Potentiates Therapy in Chemoresistant Acute Myeloid Leukemia. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504039

BibTeX
@article{He2026,
  author = {He, Chao and Zhang, Lingxiao and Xiong, Yue and Wang, Yu and Zeng, Yuqing and Su, Dandan and Wang, Ran and Li, Ying and Chen, Hongbo and Cheng, Fang and Xu, Zhi Ping},
  title = {Biomimetic Copper‐Doped Nano‐Aluminum Adjuvant Potentiates Therapy in Chemoresistant Acute Myeloid Leukemia},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202504039}
}
Kostenlos starten →